Functional contribution of elevated circulating andhepatic non-classical CD14+CD16+ monocytes to inflammation and human liver fibrosis

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Zimmermann, Henning W ^a   Seidler, Sebastian ^a   Nattermann, Jacob ^b   Gassler, Nikolaus ^a   Hellerbrand, Claus ^c   Zernecke, Alma ^a   Tischendorf, Jens J W ^a   Luedde, Tom ^a   Weiskirchen, Ralf ^a   Trautwein, Christian ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYTOKINE; CYTOKINE RECEPTOR; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADOLESCENT; ADULT; AGED; ANALYSIS; ARTICLE; BLOOD SAMPLING; CD14+ CD16+ MONOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL SUBPOPULATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; FIBROSIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFLAMMATION; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MODEL; MONOCYTE; PHENOTYPE; PROTEIN EXPRESSION; STELLATE CELL;

ANTIGENS, CD14; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MONOCYTES; RECEPTORS, IGG;

MURINAE; MUS;

EID: 77955096540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011049     Document Type: Article

References (37)

1. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548.
2. Karlmark KR, Wasmuth HE, Trautwein C, Tacke F (2008) Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2: 233-242.
3. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669-692.
4. Heymann F, Trautwein C, Tacke F (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets 8: 307-318.
5. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H (2005) Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 128: 138-146.
6. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, et al. (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50: 261-274.
7. Mitchell C, Couton D, Couty JP, Anson M, Crain AM, et al. (2009) Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol 174: 1766-1775.
8. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, et al. (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50: 185-197.
9. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, et al. (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56-65.
10. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, et al. (2007) Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110: 4077-4085.
11. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, et al. (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 119: 1858-1870.
12. Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618.
13. Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, et al. (2010) Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-19.
14. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117: 185-194.
15. Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
16. Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR (2006) Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver Int 26: 559-565.
17. Panasiuk A, Zak J, Kasprzycka E, Janicka K, Prokopowicz D (2005) Blood platelet and monocyte activations and relation to stages of liver cirrhosis. World J Gastroenterol 11: 2754-2758.
18. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332.
19. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
20. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
21. Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, et al. (2007) Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 46: 816-826.
22. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, et al. (2005) Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 42: 195-201.
23. Sakai N, Wada T, Furuichi K, Shimizu K, Kokubo S, et al. (2006) MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 79: 555-563.
24. Roderfeld M, Rath T, Voswinckel R, Dierkes C, Dietrich H, et al. (2010) Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology 51: 267-276.
25. Weiler-Normann C, Herkel J, Lohse AW (2007) Mouse models of liver fibrosis. Z Gastroenterol 45: 43-50.
26. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
27. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, et al. (1998) Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 152: 423-430.
28. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, et al. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117: 902-909.
29. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, et al. (2007) Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132: 1937-1946.
30. Schwabe RF, Bataller R, Brenner DA (2003) Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285: G949-958.
31. Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, Proudfoot AE, et al. (2007) CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am J Pathol 170: 1975-1988.
32. Tacke F, Brabant G, Kruck E, Horn R, Schoffski P, et al. (2003) Ghrelin in chronic liver disease. J Hepatol 38: 447-454.
33. Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C (2009) Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 13: R95.
34. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520.
35. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, et al. (2003) A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125: 1085-1093.
36. Hellerbrand, Wang SC, Tsukamoto H, Brenner DA, Rippe RA (1996) Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 24: 670-676.
37. Tacke F, Gabele E, Bataille F, Schwabe RF, Hellerbrand C, et al. (2007) Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 52: 3404-3415.